Current Research Studies

A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients with Acquired Hypothalamic Obesity

RM-493-040

  • Condition(s): Other
  • Phase: III
  • Clinicaltrials.gov ID: NCT04725240

What is the goal of the study?

To evaluate the efficacy of setmelanotide on change in body mass index (BMI)

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: